ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Takeda secures global rights to develop and commercialise soticlestat
March 09, 2021Takeda Pharmaceutical Company has entered into an exclusive agreement to secure global rights from Ovid Therapeutics to develop and commercialise the investigational medicine soticlestat (TAK-935/OV935) for the treatment of developmental and epileptic ... -
Aquestive Therapeutics Launches Sympazan
December 03, 2018Aquestive Therapeutics has launched Sympazan (clobazam) oral film with availability nationwide through retail pharmacies and mail order..... -
NEJM publishes second successful Epidiolex trial in LGS
July 12, 2018The New England Journal of Medicine has published the second of two late stage studies showing that GW Pharma’s cannabinoid Epidiolex cut seizures in patients with the rare childhood epilepsy Lennox-Gastaut Syndrome. -
NEJM publishes second successful Epidiolex trial in LGS
May 24, 2018In the trial - the first dose-ranging study to compare cannabidiol to placebo as add-on therapy in LGS - both doses of Epidiolex significantly reduced drop seizure frequency in patients with poor seizure control despite the use of multiple anti-epileptic
Pharma Sources Insight January 2025
